All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Compounded Semaglutide Results After 1 Year: What to Expect

What can you expect from compounded semaglutide results after 1 year? Realistic weight loss ranges, how compounded differs from brand-name, and tips...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Compounded Semaglutide Results After 1 Year: What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Compounded Semaglutide Results After 1 Year: What to Expect, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Compounded Semaglutide Results After 1 Year: What to Expect

What can you expect from compounded semaglutide results after 1 year? Realistic weight loss ranges, how compounded differs from brand-name, and tips...

Short answer

What can you expect from compounded semaglutide results after 1 year? Realistic weight loss ranges, how compounded differs from brand-name, and tips...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, peptide evidence quality

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

What can you expect from compounded semaglutide results after 1 year? Realistic weight loss ranges, how compounded differs from brand-name, and tips for success.

If you have been exploring more affordable alternatives to brand-name GLP-1 medications, you have likely come across compounded semaglutide. Many patients want to know what compounded semaglutide results after 1 year actually look like compared to branded versions. We will break down what the evidence and clinical experience tell us.

How Compounded Semaglutide Differs from Brand-Name

Compounded semaglutide contains the same active molecule as Ozempic and Wegovy, but it's prepared by a 503A or 503B compounding pharmacy rather than manufactured by Novo Nordisk. Key differences include:

  • Cost: Compounded versions are typically 50% to 80% less expensive than brand-name options From $299.
  • Formulation: Compounded semaglutide may come as a subcutaneous injection or sublingual form. The injection formulation most closely mirrors the brand-name product.
  • Regulation: Compounded medications aren't FDA-approved as finished products, but they're prepared under state pharmacy board oversight. Quality varies by pharmacy.
  • Dosing flexibility: Compounding pharmacies can prepare custom dose strengths, which some providers find helpful for fine-tuning titration schedules.

Expected Weight Loss at 12 Months

Since compounded semaglutide uses the prescribed active pharmaceutical ingredient, results should theoretically be comparable to brand-name semaglutide when dosed equivalently. Based on clinical trial data for semaglutide and real-world compounded prescribing experience: For a complete cost breakdown, see our compare semaglutide prices. For a complete cost breakdown, see our affordable GLP-1 options.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Compounded Semaglutide Results After 1 Year: What to Expect
  • At doses equivalent to Ozempic (up to 1.0 mg): Average weight loss of 8% to 12% of body weight over 12 months. For a 220-pound patient, that's roughly 18 to 26 pounds.
  • At doses equivalent to Wegovy (up to 2.4 mg): Average weight loss of 12% to 16% of body weight over 12 months. For a 220-pound patient, that's roughly 26 to 35 pounds.

Individual results depend heavily on dosing consistency, lifestyle habits, and the quality of the compounded product.

Month-by-Month Timeline

  • Months 1 to 2 (0.25 mg to 0.5 mg): Titration phase. Weight loss of 3 to 6 pounds. Appetite suppression begins to take hold. GI side effects like nausea and bloating are common but typically mild.
  • Months 3 to 4 (0.5 mg to 1.0 mg): Noticeable weight loss acceleration. Cumulative loss of 8 to 15 pounds. Food noise decreases significantly for most patients.
  • Months 5 to 7 (1.0 mg to 1.7 mg): Steady progress. Cumulative loss of 14 to 24 pounds. Many patients report improved energy, better sleep, and reduced joint pain from the weight reduction.
  • Months 8 to 10 (1.7 mg to 2.4 mg): Continued loss though the pace may slow. Cumulative loss of 18 to 30 pounds. Side effects generally stabilize.
  • Months 11 to 12: Most patients are near their maximum response at their current dose. Total loss of 18 to 35+ pounds depending on individual factors.

Factors That Affect Compounded Semaglutide Results

Several variables can influence how well compounded semaglutide works for you:

Get compounded semaglutide from $99/mo

Free provider review, personalized dosing, and ongoing support included.

Start Free Assessment →
  • Pharmacy quality: Not all compounding pharmacies produce equally reliable products. Look for pharmacies with third-party testing, cGMP standards, and established reputations.
  • Storage and handling: Compounded semaglutide requires proper refrigeration. Improper storage can degrade the peptide and reduce effectiveness.
  • Dosing accuracy: Work with a provider who has experience prescribing compounded peptides and who follows established titration protocols.
  • Lifestyle factors: Diet quality, physical activity, sleep, and stress management all influence outcomes regardless of whether you use compounded or brand-name products.
  • Starting BMI: Patients with higher starting BMIs often lose a greater absolute number of pounds, though percentage of body weight lost tends to be relatively consistent across weight ranges.

Side Effects to Expect Over 12 Months

The side effect profile for compounded semaglutide mirrors that of the brand-name versions:

  • Nausea: Most common during dose increases. Affects roughly 40% of patients at some point. Usually improves within 1 to 2 weeks at each dose level.
  • Constipation: Reported by 20% to 25% of patients. Increasing fiber and water intake helps.
  • Diarrhea: Less common than constipation but can occur, especially early in treatment.
  • Fatigue: Sometimes reported during the first few months, often related to reduced caloric intake.
  • Headaches: Occasionally reported in the first few weeks. Usually resolve on their own.

Serious side effects are rare but include pancreatitis and gallbladder complications. Regular physician monitoring is important, particularly with compounded products where post-market surveillance data is limited.

Tips for Getting the Best Results

  • Choose your pharmacy carefully: Ask your provider which compounding pharmacies they trust. Look for 503B outsourcing facilities that undergo FDA inspections.
  • Stick to the weekly schedule: Inject on the same day each week. Missed doses can disrupt steady-state drug levels.
  • Prioritize protein and vegetables: When appetite is low, make every bite count with nutrient-dense foods.
  • Exercise regularly: 150 minutes of moderate cardio plus 2 strength sessions per week supports metabolism and preserves muscle.
  • Keep your provider in the loop: Report side effects, share your progress, and get labs checked every 3 to 4 months.
  • Store your medication properly: Keep it refrigerated between 36 and 46 degrees Fahrenheit. Don't freeze.

Frequently Asked Questions

Is compounded semaglutide as effective as Ozempic or Wegovy?

When sourced from a reputable pharmacy and dosed correctly, compounded semaglutide should produce similar results to brand-name versions. The active molecule is the same. The key variable is product quality and consistency from the compounding pharmacy.

How much does compounded semaglutide cost compared to brand-name?

Compounded semaglutide typically costs between $150 and $500 per month, compared to $800 to $1,300+ for brand-name Ozempic or Wegovy without insurance From $299. This cost difference is a primary reason many patients choose compounded options.

Will my results be less than someone taking Wegovy?

Not necessarily. If the compounded product contains properly formulated semaglutide at equivalent doses, results should be comparable. The difference in outcomes is more likely related to individual biology, lifestyle habits, and dosing adherence than the source of the medication.

Yes. Compounding pharmacies operate legally under FDA guidelines and state pharmacy regulations. During the FDA-declared semaglutide shortage, 503A and 503B pharmacies were permitted to compound semaglutide. Regulatory status may evolve, so stay informed through your provider.

Should I switch to brand-name if I can afford it?

If you're getting good results with compounded semaglutide and your pharmacy is reputable, there may be no clinical reason to switch. But brand-name products offer the assurance of FDA-approved manufacturing standards and consistent formulation. Discuss the pros and cons with your physician.

Get Started with Compounded Semaglutide

A year on compounded semaglutide can produce life-changing results when combined with proper medical supervision and healthy lifestyle habits. FormBlends works with trusted compounding pharmacies and licensed providers to deliver affordable, physician-guided treatment.

Start your consultation to see if compounded semaglutide is right for you.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Compounded Semaglutide Results After 1 Year: What to Expect, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Compounded Semaglutide Results After 1 Year: What to Expect research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

What can you expect from compounded semaglutide results after 1 year? Realistic weight loss ranges, how compounded differs from brand-name, and tips for success. For "Compounded Semaglutide Results After 1 Year: What to Expect", the useful question is not just what the page says, but what a reader should confirm afterward. The page is oriented around patient education and clinical context and the specifics of semaglutide, safety and pharmacy quality. Because this article has 8 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. That makes it a planning aid, not a replacement for medical advice.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Compounded Semaglutide Results After 1 Year

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, compounded so the article stays close to the question behind "Compounded Semaglutide Results After 1 Year".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Compounded Semaglutide Results After 1 Year from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Compounded Semaglutide Results After 1 Year custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Compounded Semaglutide Results After 1 Year, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Compounded Semaglutide Results After 1 Year, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.